Quant ratings on Cathie Wood's top holdings: TSLA, CRSP, AMD, and TEM

Quant ratings on Cathie Wood's top holdings: TSLA, CRSP, AMD, and TEM
Cathie Wood’s Ark Invest leaned into volatility on Wednesday, buying shares of Tempus AI after a post-earnings pullback while trimming exposure to Pinterest following recent weakness in its outlook. Tempus AI shares fell more than 7% to $53.71 after the company reported a https://t.co/0IaJbvpWYn
Nancy Pelosi’s investment in Tempus AI is turning heads after the stock surged more than 200% this year. Earlier in 2025, Pelosi disclosed the purchase of 50 call options in Tempus AI, a healthcare-focused artificial intelligence company. The options, which expire in 2026 with a https://t.co/RQcfR1BVPT
Cathie Wood’s Ark Invest made a series of high-profile moves on Tuesday, reshuffling its portfolio across several sectors. The firm increased exposure to Advanced Micro Devices, Bullish, and Figma, while trimming its stake in Tempus AI. Ark’s Fintech Innovation ETF added nearly https://t.co/QvBQeiAvDv
Cathie Wood’s Ark Invest made several high-profile trades this week, shifting away from Tempus AI while increasing positions in Amazon, Figma, and crypto-focused Bullish. Ark sold more than 58,000 shares of Tempus AI across its ARK Genomic Revolution and ARK Innovation funds. https://t.co/DTZ8k1O1wA
Tempus AI announces $81.25M acquisition of Paige
7.48BUSD

Descubre qué milmillonarios poseen esta inversión
Tipo
Common Stock
Bolsa de Valores
NASDAQ
Código de Moneda
USD
Nombre de Moneda
US Dollar
Nombre de País
USA
ISO de País
US
ISIN
US88023B1035
CUSIP
-
Sector
Healthcare
Industria
Health Information Services
Fin del Año Fiscal
December
Fecha de IPO
-
Actualizado en
-
Ratio P/E
-
Ratio PEG
-
Valor en Libros
2.32
Dividendo por Acción
-
Rendimiento de Dividendos
-
Ganancias por Acción
-1.83
Precio Objetivo de Wall Street
67.23
Estimación de EPS para el Año Actual
-0.36
Estimación de EPS para el Próximo Año
-0.08
Estimación de EPS para el Trimestre Actual
-0.2011
Estimación de EPS para el Próximo Trimestre
-0.1483
Trimestre Más Reciente
-
Ingresos TTM
1,364,167,936
Ganancia Bruta TTM
864,734,976
EBITDA
-185,246,000
Margen de Ganancia
-22.21%
Retorno sobre Activos TTM
-9.07%
Retorno sobre Patrimonio TTM
-81.58%
Ingresos por Acción TTM
7.735
Crecimiento Trimestral de Ingresos A/A
36.10%
EPS Diluido TTM
-1.83
Crecimiento Trimestral de Ganancias A/A
0.00%
P/E Trasero
0.00
P/E Proyectado
0
Precio Ventas TTM
5.846
Precio Valor en Libros MRQ
17.9669
Valor de la Empresa sobre Ingresos
5
Valor de la Empresa sobre EBITDA
0
203.19
0.55%21.11
0.26%0.97
0.00%112.23
0.00%59.68
-18.13%5.52
-6.76%46.54
-5.87%74.71
-0.65%49.87
-0.53%100.62
-0.39%